Stock listing
OTC:MTST MetaStat Inc Stock
Follow MetaStat Inc into a list and get an email when it puts out news.
Share price · OTC:MTST
$0.0007 USD 0.0000 (0.0%)
Close on Oct 23, 2026
- Day range
- $0.0007 – $0.0007 USDOct 23, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.0001 – $0.0491 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 65 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026

Daily closes
Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:MTST · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0007 | 0.0000 | 0.0% | $0.0007 | $0.0007 | $0.0007 | 0 | |
| $0.0007 | -0.0003 | -30.0% | $0.0007 | $0.0491 | $0.0007 | 4,200 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0001 | $0.0010 | $0.0001 | 16,900 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 |
Splits
2 splits since 2011 · OTC:MTST · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation | |
| 1-for-10 | Consolidation |
- Ticker
- OTC:MTST
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Latest news
MetaStat Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 40 in all · newest Jul 16, 2018 · oldest 2015
- Decks
- 6 decks · latest Dec 4, 2015
Valuation
price Oct 23, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.07
Team and board
| Officer | Role |
|---|---|
| Steven Bartlett | Co-founder |
| Tom Lewis | Co-founder |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Nov 30, 2024 | Jan 29, 2025 | 0.0% |
| Quarter to Aug 31, 2024 | Oct 30, 2024 | 0.0% |
| Quarter to May 31, 2024 | Jul 31, 2024 | 0.0% |
| Quarter to Feb 29, 2024 | May 1, 2024 | 0.0% |
| Quarter to Nov 30, 2023 | Jan 31, 2024 | 0.0% |
| Quarter to Aug 31, 2023 | Nov 1, 2023 | 0.0% |
| Quarter to May 31, 2023 | Aug 2, 2023 | 0.0% |
| Quarter to Feb 28, 2023 | May 3, 2023 | 0.0% |
| Quarter to Nov 30, 2022 | Feb 1, 2023 | 0.0% |
| Quarter to Aug 31, 2022 | Nov 2, 2022 | 0.0% |
All 17 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to May 31, 2022 | Aug 3, 2022 | 0.0% |
| Quarter to Feb 28, 2022 | Apr 27, 2022 | 0.0% |
| Quarter to Nov 30, 2021 | Feb 2, 2022 | 0.0% |
| Quarter to Aug 31, 2021 | Nov 3, 2021 | 0.0% |
| Quarter to May 31, 2021 | Jul 28, 2021 | 0.0% |
| Quarter to Feb 28, 2021 | Apr 28, 2021 | 0.0% |
| Quarter to Nov 30, 2020 | Feb 3, 2021 | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2015) | Investor deck | 23 slides | Dec 4, 2015 |
| Investor Presentation (September 2015) | Investor deck | 26 slides | Sep 9, 2015 |
| Investor Presentation (February 2015) | Investor deck | 28 slides | Feb 26, 2015 |
| Rodman & Renshaw 2014 Annual Global Investment Conference | Conference | 23 slides | Sep 10, 2014 |
| Investor Presentation (January 2014) | Investor deck | 33 slides | Jan 15, 2014 |
| Investor Presentation (December 2012) | Investor deck | 22 slides | Dec 20, 2012 |
Financials
Annual, in USD
Income statement
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.3K | 0 | 0 | 0 | 0 | |||||
| Cost of revenue | 1.26M | 1.01M | 0 | 0 | 0 | |||||
| Gross profit | 23.3K | -1.01M | 0 | 0 | 0 | |||||
| Research and development | 1.26M | 1.01M | 1.36M | 1.27M | 824.3K | 516.8K | ||||
| Selling, general and administrative | 2.32M | 2.34M | 3.42M | 3.52M | 3.53M | 1.76M | ||||
| Operating income | -3.55M | 3.35M | 4.78M | 4.79M | 4.35M | 2.52M | ||||
| Depreciation and amortization | 228.5K | 236.6K | 206.3K | 171.9K | 89.2K | 95.8K | 96.2K | 61.9K | 21.8K | 11.1K |
| EBITDA | -3.46M | 3.44M | 4.88M | 4.85M | 4.37M | 2.53M | ||||
| Interest expense | 119.3K | 1.06M | 317.2K | 95.0K | 137.1K | 0 | ||||
| Income before tax | -3.18M | -2.94M | -4.65M | -8.00M | -5.37M | -2.52M | ||||
| Income tax | 119.9K | 1.06M | 317.2K | 95.0K | 137.1K | 229.6K | ||||
| Net income | -3.18M | -2.94M | -4.65M | -8.00M | -5.37M | -2.52M | ||||
| Earnings per share, basic | -0.59 | -0.99 | -2.56 | -4.81 | -3.80 | -1.81 |
Balance sheet
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 316.9K | 782.7K | 363.8K | 257.8K | 483.4K | 969.2K | ||||
| Receivables | 125.0K | 125.0K | 20.0K | 20.0K | ||||||
| Current assets | 331.9K | 803.6K | 521.9K | 296.6K | 576.0K | 969.2K | ||||
| Property, plant and equipment | 354.1K | 414.6K | 497.1K | 526.6K | 205.0K | 54.0K | ||||
| Total assets | 729.6K | 1.26M | 1.06M | 1.10M | 790.6K | 1.02M | ||||
| Accounts payable | 571.6K | 571.6K | 572.2K | 746.1K | 293.2K | 258.0K | ||||
| Current liabilities | 2.08M | 1.95M | 2.60M | 416.8K | 2.87M | 886.9K | ||||
| Long-term debt | 170.0K | |||||||||
| Total debt | 1.00M | 989.1K | 1.53M | 269.6K | 2.48M | 717.0K | ||||
| Total liabilities | 2.28M | 4.06M | 2.83M | 859.5K | 2.87M | 886.9K | ||||
| Shareholders' equity | -1.55M | -2.80M | -1.77M | 242.7K | -2.08M | 135.6K | ||||
| Shares outstanding | 5.43M | 5.43M | 5.43M | 5.43M | 5.43M | 2.97M | 1.82M | 1.66M | 1.41M | 1.39M |
Cash flow
| Line | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|
| Cash from operations | -2.74M | -2.31M | -3.14M | -3.58M | -2.20M | -2.40M |
| Capital spending | -30.1K | -13.4K | -151.8K | -65.6K | -172.7K | -45.2K |
| Free cash flow | -2.77M | -2.33M | -3.29M | -3.65M | -2.37M | -2.44M |
| Cash from investing | -30.1K | -921 | -48.9K | 1.15M | -172.7K | -45.2K |
| Cash from financing | 2.31M | 2.73M | 3.30M | 2.21M | 1.89M | 2.53M |
| Share buybacks | 2.31M | 0 | 2.75M | 711.1K | 711.1K | |
| Change in cash | -465.8K | 418.9K | 106.0K | -225.6K | -485.8K | 90.8K |
Cap table
Built by 6ix from MetaStat Inc’s releases
- Common shares
- 5,877,383
- Fully diluted
- 5,877,383
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,877,383 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,877,383 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jerome Zeldis Other companies: NexGel, Inc (Director · Since at least Mar 8, 2021); PTC Therapeutics, Inc. (Director · Since at least Jun 19, 2013); Soligenix, Inc. (Board Director · Since at least Jun 22, 2011); NexImmune, Inc. (Executive VP of Research & Dev · Feb 11, 2021 – Apr 5, 2022 · Past); Beyond Air, Inc. (Director · Mar 14, 2017 – Mar 14, 2017 · Past); Sorrento Therapeutics, Inc. (See Remarks · Aug 12, 2016 – Nov 26, 2018 · Past); Streamex Corp. (Director · Jul 20, 2015 – Jul 14, 2020 · Past) | Director · Oct 11, 2017 – Oct 11, 2017 · Past |
| Martin J Driscoll Other companies: Spring Bank Pharmaceuticals Inc (President and CEO, Director · May 5, 2016 – Mar 5, 2020 · Past) | Director · Aug 5, 2015 – Aug 5, 2015 · Past |
| Paul Billings Other companies: Cardiff Oncology, Inc. (Director · Oct 30, 2013 – Jan 23, 2018 · Past) | Director · May 24, 2017 – Oct 11, 2017 · Past |
| Douglas A Hamilton | PRESIDENT AND CEO · Jun 17, 2015 – Oct 11, 2017 · Past |
Log in to ask 6ix AI your own questions about MetaStat Inc.